This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04020/identifier/pdb/
n8http://bio2rdf.org/drugbank:
n4http://linked.opendata.cz/resource/drugbank/drug/DB04020/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04020/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04020/identifier/drugbank/
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04020
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n8:DB04020 n9:DB04020
dcterms:title
4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol
adms:identifier
n4:9957008 n10:DB04020 n12:46505687 n13:MON
n5:IUPAC-Name
n6:271B5954-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B595A-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5959-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5956-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5957-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5958-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5952-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5953-363D-11E5-9242-09173F13E4C5 n6:271B5950-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5951-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5960-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5961-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B595B-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B595C-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B595E-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B595D-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B595F-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5966-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5968-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5969-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5965-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5964-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5967-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5955-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5962-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5963-363D-11E5-9242-09173F13E4C5